Cav3.2 T-type calcium channel is required for the NFAT-dependent Sox9 expression in tracheal cartilage

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 19, 2014, Pages

  Lin, Shin Shiou ^a,b   Tzeng, Bing Hsiean ^b,c   Lee, Kuan Rong ^a   Smith, Richard J H ^d   Campbell, Kevin P ^e,f   Chen, Chien Chang ^b  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^d Departments of Otolaryngology Internal Medicine Pediatrics and Molecular Physiology and Biophysics ^*  (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM CHANNEL T TYPE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR SOX9; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CALCIUM SIGNALING; CALCIUM TRANSPORT; CARTILAGE; CARTILAGINOUS TISSUE; CELL DIFFERENTIATION; CHONDROGENESIS; GENE OVEREXPRESSION; LUCIFERASE ASSAY; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEX DETERMINATION; T LYMPHOCYTE; TRACHEA; TRACHEA STENOSIS; Y CHROMOSOME;

ANIMALS; CALCINEURIN; CALCIUM CHANNELS, T-TYPE; CARTILAGE; CELLS, CULTURED; CHONDROCYTES; CHONDROGENESIS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED ICR; MICE, KNOCKOUT; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; SOX9 TRANSCRIPTION FACTOR; TRACHEA;

EID: 84900513584     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1323112111     Document Type: Article

References (92)

1. Carden KA, Boiselle PM, Waltz DA, Ernst A (2005) Tracheomalacia and tracheo-bronchomalacia in children and adults: An in-depth review. Chest 127(3):984-1005.
2. Phipps LM, Raymond JA, Angeletti TM (2006) Congenital tracheal stenosis. Crit Care Nurse 26(3):60-69.
3. Rutter MJ, Willging JP, Cotton RT (2004) Nonoperative management of complete tracheal rings. Arch Otolaryngol Head Neck Surg 130(4):450-452.
4. Que J, Choi M, Ziel JW, Klingensmith J, Hogan BL (2006) Morphogenesis of the trachea and esophagus: Current players and new roles for noggin and Bmps. Differentiation 74(7):422-437.
5. Perl A-KT, Wert SE, Nagy A, Lobe CG, Whitsett JA (2002) Early restriction of peripheral and proximal cell lineages during formation of the lung. Proc Natl Acad Sci USA 99(16):10482-10487.
6. Miller LA, et al. (2004) Role of Sonic hedgehog in patterning of tracheal-bronchial cartilage and the peripheral lung. Dev Dyn 231(1):57-71.
7. Rock JR, Futtner CR, Harfe BD (2008) The transmembrane protein TMEM16A is required for normal development of the murine trachea. Dev Biol 321(1):141-149.
8. Geng Y, et al. (2011) Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc Natl Acad Sci USA 108(17):7058-7063.
9. Foster JW, et al. (1994) Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene. Nature 372(6506):525-530.
10. Kwok C, et al. (1995) Mutations in SOX9, the gene responsible for Campomelic dys-plasia and autosomal sex reversal. Am J Hum Genet 57(5):1028-1036.
11. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B (1999) Sox9 is required for cartilage formation. Nat Genet 22(1):85-89.
12. Ng LJ, et al. (1997) SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183(1):108-121.
13. Zhao Q, Eberspaecher H, Lefebvre V, De Crombrugghe B (1997) Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209(4):377-386.
14. Akiyama H, Chaboissier MC, Martin JF, Schedl A, de Crombrugghe B (2002) The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16(21):2813-2828.
15. Wagner T, et al. (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79(6):1111-1120.
16. Bi W, et al. (2001) Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98(12):6698-6703.
17. Akiyama H, et al. (2004) Interactions between Sox9 and beta-catenin control chon-drocyte differentiation. Genes Dev 18(9):1072-1087.
18. Shao Y, Alicknavitch M, Farach-Carson MC (2005) Expression of voltage sensitive calcium channel (VSCC) L-type Cav1.2 (alpha1C) and T-type Cav3.2 (alpha1H) subunits during mouse bone development. Dev Dyn 234(1):54-62.
19. Mancilla EE, et al. (2007) L-type calcium channels in growth plate chondrocytes participate in endochondral ossification. J Cell Biochem 101(2):389-398.
20. Matta C, et al. (2008) Cytosolic free Ca2+ concentration exhibits a characteristic temporal pattern during in vitro cartilage differentiation: A possible regulatory role of calcineurin in Ca-signalling of chondrogenic cells. Cell Calcium 44(3):310-323.
21. Bergh JJ, Shao Y, Puente E, Duncan RL, Farach-Carson MC (2006) Osteoblast Ca(2+) permeability and voltage-sensitive Ca(2+) channel expression is temporally regulated by 1, 25-dihydroxyvitamin D(3). Am J Physiol Cell Physiol 290(3):C822-C831.
22. Senatore A, Spafford JD (2012) Gene transcription and splicing of T-type channels are evolutionarily-conserved strategies for regulating channel expression and gating. PLoS ONE 7(6):e37409.
23. Catterall WA (2011) Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 3(8):a003947.
24. Perez-Reyes E, Lory P (2006) Molecular biology of T-type calcium channels. CNS Neurol Disord Drug Targets 5(6):605-609.
25. Chen Y, et al. (2003) Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol 54(2):239-243.
26. Zhong X, Liu JR, Kyle JW, Hanck DA, Agnew WS (2006) A profile of alternative RNA splicing and transcript variation of CACNA1H, a human T-channel gene candidate for idiopathic generalized epilepsies. Hum Mol Genet 15(9):1497-1512.
27. Heron SE, et al. (2007) Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol 62(6):560-568.
28. Chen CC, et al. (2003) Abnormal coronary function in mice deficient in alpha1H T-type Ca2+ channels. Science 302(5649):1416-1418.
29. Chiang CS, et al. (2009) The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 104(4):522-530.
30. Shin HS, Cheong EJ, Choi S, Lee J, Na HS (2008) T-type Ca2+ channels as therapeutic targets in the nervous system. Curr Opin Pharmacol 8(1):33-41.
31. Chen WK, et al. (2010) Ca(v)3.2 T-type Ca2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. J Neurosci 30(31):10360-10368.
32. Wang R, Lewin GR (2011) The Cav3.2 T-type calcium channel regulates temporal coding in mouse mechanoreceptors. J Physiol 589(Pt 9):2229-2243.
33. Chen CC, et al. (2012) Retrieval of context-associated memory is dependent on the Ca(v)3.2 T-type calcium channel. PLoS ONE 7(1):e29384.
34. Park J, et al. (2010) Regulation of Sox9 by Sonic Hedgehog (Shh) is essential for patterning and formation of tracheal cartilage. Dev Dyn 239(2):514-526.
35. Que J, et al. (2007) Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development 134(13):2521-2531.
36. Atsumi T, Miwa Y, Kimata K, Ikawa Y (1990) A chondrogenic cell line derived from a differentiating culture of AT805 teratocarcinoma cells. Cell Differ Dev 30(2):109-116.
37. Huang L, et al. (2004) NNC 55-0396 [(1S, 2S)-2-(2-(N-[(3-benzimidazol-2- yl)propyl]-N-meth-ylamino)ethyl)-6-fluoro-1, 2, 3, 4-tetrahydro-1-isopropyl-2- naphtyl cyclopropanecarboxylate dihydrochloride]: A new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 309(1):193-199.
38. Tomita M, Reinhold MI, Molkentin JD, Naski MC (2002) Calcineurin and NFAT4 induce chondrogenesis. J Biol Chem 277(44):42214-42218.
39. Huang CH, Chen YC, Chen CC (2013) Physical interaction between calcineurin and Cav3.2 T-type Ca2+ channel modulates their functions. FEBS Lett 587(12):1723-1730.
40. Wilkins BJ, et al. (2004) Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res 94(1):110-118.
41. Martin JF, Bradley A, Olson EN (1995) The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages. Genes Dev 9(10): 1237-1249.
42. Akiyama H, et al. (2005) Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors. Proc Natl Acad Sci USA 102(41):14665-14670.
43. Sekiya I, et al. (2000) SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 275(15): 10738-10744.
44. Lefebvre V, Huang W, Harley VR, Goodfellow PN, de Crombrugghe B (1997) SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17(4):2336-2346.
45. Akiyama H (2008) Control of chondrogenesis by the transcription factor Sox9. Mod Rheumatol 18(3):213-219.
46. Morishita M, et al. (2001) A 30-base-pair element in the first intron of SOX9 acts as an enhancer in ATDC5. Biochem Biophys Res Commun 288(2):347-355.
47. Xie X, et al. (2007) Validation of high throughput screening assays against three subtypes of Ca(v)3 T-type channels using molecular and pharmacologic approaches. Assay Drug Dev Technol 5(2):191-203.
48. Messeguer X, et al. (2002) PROMO: Detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18(2):333-334.
49. Zuscik MJ, Hilton MJ, Zhang X, Chen D, O'Keefe RJ (2008) Regulation of chondro-genesis and chondrocyte differentiation by stress. J Clin Invest 118(2):429-438.
50. Lory P, Bidaud I, Chemin J (2006) T-type calcium channels in differentiation and proliferation. Cell Calcium 40(2):135-146.
51. Li Y, et al. (2009) A role of functional T-type Ca2+ channel in hepatocellular carcinoma cell proliferation. Oncol Rep 22(5):1229-1235.
52. Thompson WR, et al. (2011) Association of the α(2)δ(1) subunit with Ca(v)3.2 enhances membrane expression and regulates mechanically induced ATP release in MLO-Y4 osteocytes. J Bone Miner Res 26(9):2125-2139.
53. Choi J, et al. (2005) T-type calcium channel trigger p21ras signaling pathway to ERK in Cav3.1-expressed HEK293 cells. Brain Res 1054(1):22-29.
54. Nakayama H, et al. (2009) alpha1G-dependent T-type Ca2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest 119(12):3787-3796.
55. Yao J, et al. (2006) Molecular basis for the modulation of native T-type Ca2+ channels in vivo by Ca2+/calmodulin-dependent protein kinase II. J Clin Invest 116(9): 2403-2412.
56. Rodman DM, et al. (2005) Low-voltage-activated (T-type) calcium channels control proliferation of human pulmonary artery myocytes. Circ Res 96(8):864-872.
57. Pluteanu F, Cribbs LL (2011) Regulation and function of Cav3.1 T-type calcium channels in IGF-I-stimulated pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 300(3):C517-C525.
58. Tzeng BH, et al. (2012) The Cav3.1 T-type calcium channel is required for neointimal formation in response to vascular injury in mice. Cardiovasc Res 96(3):533-542.
59. Lu F, et al. (2008) T-type Ca2+ channel expression in human esophageal carcinomas: A functional role in proliferation. Cell Calcium 43(1):49-58.
60. Toyota M, Ho C, Ohe-Toyota M, Baylin SB, Issa JP (1999) Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res 59(18):4535-4541.
61. Oguri A, et al. (2010) Involvement of CaV3.1 T-type calcium channels in cell proliferation in mouse preadipocytes. Am J Physiol Cell Physiol 298(6):C1414-C1423.
62. Bijlenga P, et al. (2000) T-type alpha 1H Ca2+ channels are involved in Ca2+ signaling during terminal differentiation (fusion) of human myoblasts. Proc Natl Acad Sci USA 97(13):7627-7632.
63. Chemin J, Nargeot J, Lory P (2002) Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. J Neurosci 22(16):6856-6862.
64. Kushmerick C, Romano-Silva MA, Gomez MV, Prado MA (2001) Changes in Ca(2+) channel expression upon differentiation of SN56 cholinergic cells. Brain Res 916(1-2): 199-210.
65. Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N (2002) Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 277(13):10824-10833.
66. Senatore A, Zhorov BS, Spafford JD (2012) Cav3 T-type calcium channels. Wiley In-terdiscip Rev Membr Transp Signal 1(4):467-491.
67. Ramage L, Martel MA, Hardingham GE, Salter DM (2008) NMDA receptor expression and activity in osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 16(12):1576-1584.
68. Salter DM, Wright MO, Millward-Sadler SJ (2004) NMDA receptor expression and roles in human articular chondrocyte mechanotransduction. Biorheology 41(3-4):273-281.
69. Fodor J, et al. (2013) Store-operated calcium entry and calcium influx via voltage-operated calcium channels regulate intracellular calcium oscillations in chondrogenic cells. Cell Calcium 54(1):1-16.
70. Jahr H, van Driel M, van Osch GJ, Weinans H, van Leeuwen JP (2005) Identification of acid-sensing ion channels in bone. Biochem Biophys Res Commun 337(1):349-354.
71. Gavenis K, et al. (2009) Expression of ion channels of the TRP family in articular chondrocytes from osteoarthritic patients: Changes between native and in vitro propagated chondrocytes. Mol Cell Biochem 321(1-2):135-143.
72. O'Conor CJ, Leddy HA, Benefield HC, Liedtke WB, Guilak F (2014) TRPV4-mediated mechanotransduction regulates the metabolic response of chondrocytes to dynamic loading. Proc Natl Acad Sci USA 111(4):1316-1321.
73. Clark AL, Votta BJ, Kumar S, Liedtke W, Guilak F (2010) Chondroprotective role of the osmotically sensitive ion channel transient receptor potential vanilloid 4: Age-and sex-dependent progression of osteoarthritis in Trpv4-deficient mice. Arthritis Rheum 62(10):2973-2983.
74. Liu Y, Li H, Tanaka K, Tsumaki N, Yamada Y (2000) Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene. J Biol Chem 275(17):12712-12718.
75. Piera-Velazquez S, et al. (2007) Regulation of the human SOX9 promoter by Sp1 and CREB. Exp Cell Res 313(6):1069-1079.
76. Ushita M, et al. (2009) Transcriptional induction of SOX9 by NF-kappaB family member RelA in chondrogenic cells. Osteoarthritis Cartilage 17(8):1065-1075.
77. Colter DC, et al. (2005) Regulation of the human Sox9 promoter by the CCAAT-binding factor. Matrix Biol 24(3):185-197.
78. Bradley EW, Drissi MH (2010) WNT5A regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-kappaB pathways. Mol Endocrinol 24(8): 1581-1593.
79. de Jong EM, et al. (2010) 5q11.2 deletion in a patient with tracheal agenesis. Eur J Hum Genet 18(11):1265-1268.
80. Hockstein NG, et al. (2004) Tracheal anomalies in Pfeiffer syndrome. Arch Otolaryngol Head Neck Surg 130(11):1298-1302.
81. Furtado LV, et al. (2011) Unilateral sclerocornea and tracheal stenosis: Unusual findings in a patient with Goldenhar anomaly. Fetal Pediatr Pathol 30(6):397-404.
82. Li BC, et al. (2013) Clinical report: Two patients with atelosteogenesis type I caused by missense mutations affecting the same FLNB residue. Am J Med Genet A 161A(3): 619-625.
83. Bell SM, et al. (2008) R-spondin 2 is required for normal laryngeal-tracheal, lung and limb morphogenesis. Development 135(6):1049-1058.
84. Li C, Xiao J, Hormi K, Borok Z, Minoo P (2002) Wnt5a participates in distal lung morphogenesis. Dev Biol 248(1):68-81.
85. Geng Y, et al. (2011) Follistatin-like 1 (Fstl1) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development. Proc Natl Acad Sci USA 108(17):7058-7063.
86. Li Y, Gordon J, Manley NR, Litingtung Y, Chiang C (2008) Bmp4 is required for tra-cheal formation: A novel mouse model for tracheal agenesis. Dev Biol 322(1):145-155.
87. Tiozzo C, et al. (2009) Fibroblast growth factor 10 plays a causative role in the tracheal cartilage defects in a mouse model of Apert syndrome. Pediatr Res 66(4):386-390.
88. Sala FG, et al. (2011) FGF10 controls the patterning of the tracheal cartilage rings via Shh. Development 138(2):273-282.
89. Lerman G, et al. (2011) MiRNA expression in psoriatic skin: Reciprocal regulation of hsa-miR-99a and IGF-1R. PLoS ONE 6(6):e20916.
90. Bonvin E, et al. (2008) Congenital tracheal malformation in cystic fibrosis trans-membrane conductance regulator-deficient mice. J Physiol 586(13):3231-3243.
91. Hsu SC, Chang YT, Chen CC (2013) Early growth response 1 is an early signal inducing Cav3.2 T-type calcium channels during cardiac hypertrophy. Cardiovasc Res 100(2): 222-230.
92. Lee TI, Johnstone SE, Young RA (2006) Chromatin immunoprecipitation and micro-array-based analysis of protein location. Nat Protoc 1(2):729-748.